|1.||Criner, Gerard J: 2 articles (08/2010 - 05/2009)|
|2.||Celli, Bartolome R: 1 article (08/2010)|
|3.||Berger, Robert L: 1 article (08/2010)|
|4.||Decamp, Malcolm M: 1 article (08/2010)|
|5.||Dransfield, M: 1 article (07/2010)|
|6.||Gotfried, M: 1 article (07/2010)|
|7.||Krasna, M: 1 article (07/2010)|
|8.||Tewari, S: 1 article (07/2010)|
|9.||Leeds, W: 1 article (07/2010)|
|10.||Refaely, Y: 1 article (07/2010)|
07/01/2010 - "BioLVR therapy with 20 mL per site at eight subsegmental sites may be a safe and effective therapy in patients with advanced homogeneous emphysema."
07/01/2010 - "BioLVR therapy was administered bronchoscopically to 25 patients with homogeneous emphysema in an open-labelled study. "
05/01/2009 - "BioLVR improves physiology and functional outcomes up to 6 months with an acceptable safety profile in upper lobe predominant emphysema. "
05/01/2009 - "Assess the safety and therapeutic dose of BioLVR hydrogel in upper lobe predominant emphysema. "
07/01/2010 - "This report summarises phase 2 trial results of biologic lung volume reduction (BioLVR) for treatment of advanced homogeneous emphysema. "
08/01/2010 - "The following three methods have been tested in some depth: (1) unidirectional valves that allow exit but bar entry of gas to collapse targeted hyperinflated portions of the lung and reduce overall volume; (2) biologic lung volume reduction (BioLVR) that involves intrabronchial administration of a biocompatible complex to collapse, inflame, scar, and shrink the targeted emphysematous lung; and (3) airway bypass tract (ABT) or creation of stented nonanatomic pathways between hyperinflated pulmonary parenchyma and bronchial tree to decompress and reduce the volume of oversized lung. "
|1.||Pneumonectomy (Lung Volume Reduction)